You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
McKinsey
Express Scripts
AstraZeneca
Colorcon

Last Updated: May 13, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Hetrombopag

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Hetrombopag?

Hetrombopag is an investigational drug.

There have been 12 clinical trials for Hetrombopag. The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2019.

The most common disease conditions in clinical trials are Purpura, Thrombocytopenic, Idiopathic, Purpura, Thrombocytopenic, and Purpura. The leading clinical trial sponsors are Jiangsu HengRui Medicine Co., Ltd. and [disabled in preview].

There are three US patents protecting this investigational drug.

Recent Clinical Trials for Hetrombopag
TitleSponsorPhase
Hetrombopag for Pediatric Patients With Chronic Immune ThrombocytopeniaJiangsu HengRui Medicine Co., Ltd.Phase 3
Relative Bioavailability of Early Phase and Late Phase Hetrombopag Olamine FormulationsJiangsu HengRui Medicine Co., Ltd.Phase 1
Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.Jiangsu HengRui Medicine Co., Ltd.Phase 3

See all Hetrombopag clinical trials

Clinical Trial Summary for Hetrombopag

Top disease conditions for Hetrombopag
Top clinical trial sponsors for Hetrombopag

See all Hetrombopag clinical trials

US Patents for Hetrombopag

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Hetrombopag   Get Started for $10 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof Jiangsu Hengrui Medicine Co. Ltd. (Jiangsu, CN) Shanghai Hengrui Pharmaceutical Co. Ltd. (Shanghai, CN)   Get Started for $10
Hetrombopag   Get Started for $10 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof Jiangsu Hengrui Medicine Co., Ltd. (CN) Shanghai Hengrui Pharmaceutical Co., Ltd. (CN)   Get Started for $10
Hetrombopag   Get Started for $10 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof Jiangsu Hengrui Medicine Co., Ltd. (CN) Shanghai Hengrui Pharmaceutical Co., Ltd. (CN)   Get Started for $10
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Baxter
Medtronic
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.